Inactivator of the Third Component of Complement as an Inhibitor in the Properdin Pathway
- 1 October 1972
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 69 (10), 2910-2913
- https://doi.org/10.1073/pnas.69.10.2910
Abstract
Evidence has been obtained that a single protein, known to modulate classical complement activation, also acts as an inhibitor in the properdin or alternate complement pathway. A highly purified inactivator of the third component of complement (C3) from human serum inhibited the proteolysis of Factor B in the properdin system (glycine-rich beta-glycoprotein) by glycine-rich beta-glycoproteinase. The inhibition was by the enzymatic destruction of glycine-rich beta-glycoproteinase activity. The major fragment of C3, C3b, which is the only known substrate of the C3 inactivator, blocked the destruction of glycine-rich beta-glycoproteinase by the C3 inactivator. Thus, in its inhibition of the porperdin pathway, the C3 inactivator destroys both the active form of glycine-rich beta-glycoproteinase and a protein involved in the conversion of the zymogen form of this enzyme (proglycine-rich beta-glycoproteinase) to its active form. The increased susceptibility to infections in a patient homozygous for deficiency of the C3 inactivator demonstrates the biologic significance of this protein.Keywords
This publication has 16 references indexed in Scilit:
- THE C3-ACTIVATOR SYSTEM: AN ALTERNATE PATHWAY OF COMPLEMENT ACTIVATIONThe Journal of Experimental Medicine, 1971
- C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.1971
- Deficiency of C3 Inactivator in ManThe Journal of Immunology, 1971
- Isolation and properties of a glycine-rich β-glycoprotein of human serumBiochimica et Biophysica Acta (BBA) - Protein Structure, 1970
- Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infectionJournal of Clinical Investigation, 1970
- Increased Susceptibility to Infection Associated with Abnormalities of Complement-Mediated Functions and of the Third Component of Complement (C3)New England Journal of Medicine, 1970
- The Demonstration in Human Serum of “Conglutinogen-Activating Factor” and its Effect on the Third Component of ComplementThe Journal of Immunology, 1968
- Studies of the In Vivo Behavior of Human C′3 in Normal Subjects and Patients*Journal of Clinical Investigation, 1967
- Three Naturally-Occurring Inhibitors of Components of Complement in Guinea Pig and Rabbit SerumThe Journal of Immunology, 1967
- Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesAnalytical Biochemistry, 1966